AU2002316299A1 - Ppar-alpha ligands for the treatment or prevention of cachexia - Google Patents

Ppar-alpha ligands for the treatment or prevention of cachexia

Info

Publication number
AU2002316299A1
AU2002316299A1 AU2002316299A AU2002316299A AU2002316299A1 AU 2002316299 A1 AU2002316299 A1 AU 2002316299A1 AU 2002316299 A AU2002316299 A AU 2002316299A AU 2002316299 A AU2002316299 A AU 2002316299A AU 2002316299 A1 AU2002316299 A1 AU 2002316299A1
Authority
AU
Australia
Prior art keywords
ppar
cachexia
prevention
treatment
alpha ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002316299A
Inventor
Samuel D. Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU2002316299A1 publication Critical patent/AU2002316299A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002316299A 2001-06-22 2002-06-19 Ppar-alpha ligands for the treatment or prevention of cachexia Abandoned AU2002316299A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30027401P 2001-06-22 2001-06-22
US60/300,274 2001-06-22
PCT/US2002/019464 WO2003000182A2 (en) 2001-06-22 2002-06-19 Ppar-alpha ligands for the treatment or prevention of cachexia

Publications (1)

Publication Number Publication Date
AU2002316299A1 true AU2002316299A1 (en) 2003-01-08

Family

ID=23158415

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002316299A Abandoned AU2002316299A1 (en) 2001-06-22 2002-06-19 Ppar-alpha ligands for the treatment or prevention of cachexia

Country Status (2)

Country Link
AU (1) AU2002316299A1 (en)
WO (1) WO2003000182A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2577601A1 (en) 2004-08-13 2006-02-16 Indivumed Gmbh Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9606805D0 (en) * 1996-03-30 1996-06-05 Glaxo Wellcome Inc Medicaments
US5925657A (en) * 1997-06-18 1999-07-20 The General Hospital Corporation Use of PPARγ agonists for inhibition of inflammatory cytokine production

Also Published As

Publication number Publication date
WO2003000182A2 (en) 2003-01-03
WO2003000182A3 (en) 2003-05-08

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2935200A (en) Compounds for the treatment of obesity
AU2002348135A1 (en) Methods for the treatment of addiction
AU2002364300A1 (en) Polymer derivatives for the treatment of metals
EP1390029A4 (en) Phenylindoles for the treatment of hiv
HRP20040906B1 (en) Bisphosphonic acid for the treatment and prevention of ostreoporosis
AU2002303502A1 (en) Improved leads for the treatment of patients with chf
GB2418025B (en) Device for the prevention or treatment of ulcers
EP1442062A4 (en) Methods for the treatment of carcinoma
AU2003263760A1 (en) Methods for the treatment or prevention of obesity
AU4136901A (en) Novel methods for the treatment and prevention of dizziness and pruritus
PL377464A1 (en) Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
AU5038299A (en) Process for the biocidal treatment of surfaces
AU2002364171A1 (en) Materials and methods for the treatment or prevention of obesity
EP1461030A4 (en) Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
AU2002249947A1 (en) Inhibition of protein-phosphatases for the treatment of heart failure
AU2001285156A1 (en) Combination therapy for the treatment of migraine
AU2002304883A1 (en) Device for the treatment of tumours
AU2002316299A1 (en) Ppar-alpha ligands for the treatment or prevention of cachexia
AU2002365621A1 (en) Composition for treating the surface of the skin
AU2003268939A1 (en) Bisphosphonates for the treatment of antheroscleorosis and devices comprising them
AU2002251202A1 (en) Intimins for the prevention or treatment of infections: i
AU2000272704A1 (en) Use of compounds for the treatment of obesity
AU1792200A (en) Use of phanquinone for the treatment or prevention of memory impairment
AUPR814901A0 (en) Water treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase